Robertson Eden G, Wakefield Claire E, Tsoli Maria, Kellie Stewart J, Alvaro Frank, Gifford Andrew J, Weber Martin A, Rodriguez Michael, Kirby Maria, Ziegler David S
School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
Neurooncol Adv. 2021 Aug 25;3(1):vdab087. doi: 10.1093/noajnl/vdab087. eCollection 2021 Jan-Dec.
Pediatric high-grade glioma is a devastating diagnosis. There has been no improvement in outcomes for several decades, with few children surviving 2 years postdiagnosis. Research progress has been hampered by a lack of tumor samples, which can be used to develop and test novel therapies. Postmortem tumor donations are therefore a valuable opportunity to collect tissue. In this study, we explored Australian parents' experiences of donating their child's tumor for research after their child had died.
We collected qualitative data from 11 bereaved parents who consented to donate samples of their child's high-grade glioma for research postmortem. We asked parents about their perceived benefits/burdens of the autopsy, recommendations for improving consent discussions, and decision regret.
Parents hoped that their donation would help to find a cure for future children with high-grade glioma. They described feeling comforted knowing that their child's suffering may help others. Some parents also felt that the donation would help them better understand their child's tumor. Although some parents described discomfort about procedures leading up to the autopsy, parents reported minimal regret regarding their decision to donate their child's tumor. Parents provided recommendations to improve consent discussions, such as providing more information about the autopsy logistics and why the donation was needed.
Parents consented to autopsy for altruistic reasons, although donation may also assist parents in their grieving. There is a strong need to improve access to tumor donations for any family who wishes to donate.
小儿高级别胶质瘤是一个毁灭性的诊断结果。几十年来,其治疗效果一直没有改善,很少有儿童在确诊后存活两年。由于缺乏可用于开发和测试新疗法的肿瘤样本,研究进展受到阻碍。因此,死后肿瘤捐赠是收集组织的一个宝贵机会。在本研究中,我们探讨了澳大利亚父母在孩子去世后捐赠其孩子肿瘤用于研究的经历。
我们从11位同意在孩子死后捐赠其高级别胶质瘤样本用于研究的丧亲父母那里收集了定性数据。我们询问了父母关于他们对尸检的感知益处/负担、对改善同意讨论的建议以及决策后悔情况。
父母们希望他们的捐赠能有助于找到治愈未来小儿高级别胶质瘤患儿的方法。他们表示知道自己孩子的痛苦可能会帮助他人会感到欣慰。一些父母还觉得捐赠会帮助他们更好地了解孩子的肿瘤。尽管一些父母描述了对尸检前程序感到不适,但父母们表示对捐赠孩子肿瘤的决定几乎没有后悔。父母们提供了改善同意讨论的建议,比如提供更多关于尸检流程以及为何需要捐赠的信息。
父母出于利他主义原因同意进行尸检,尽管捐赠也可能有助于父母缓解悲痛。对于任何希望捐赠的家庭来说,迫切需要改善获取肿瘤捐赠的途径。